1 Service de Pneumologie et d'Allergologie Pédiatriques Hôpital des Enfants Malades 75015 Paris, France
2 Service de Radiologie Pediatrique Hôpital des Enfants Malades 75015 Paris, France
3 Service d'Anatomie-Pathologie Hôpital des Enfants Malades 75015 Paris, France
4 Service de Pédiatrie Hôpital Lyon-Sud Chemin Revoyet 69310 Pierre Bénite
We report eight pediatric cases of pulmonary alveolar proteinosis (PAP) that illustrate the poly-morphic nature of this disease: two cases with severe neonatal onset, three cases with progressive respiratory distress in patients under 1 year old, and three cases in older children with mild symptoms. Consanguineous parents or affected siblings were identified or suspected in four families. Three patients suffered from associated immune or blood disorders (severe combined immune deficiency, myelodysplasia). The respective roles of a macrophagic dysfunction and of an anomaly of the surfactant are discussed according to the various clinical presentations of pediatric PAP.
We performed eight uniltateral pulmonary lavages under endoscopy and selective ventilation for two patients under 7 kg in weight. These interventions led to progressive discontinuation of oxygen therapy in one case, and temporarily stabilized the disease for the second. Subsequent recurrence in this second patient was treated by massive lavage under extracorporeal oxygenation. A third infant was successfully transplanted with no recurrence within 3 years. Ambroxol was administered in one case. The three oldest children of our series remained asymptomatic, whereas three of the younger patients died. In the light of this experience, we propose that the treatment administered should be determined according to the age of the patient, the degree of respiratory deficiency, and the nature of any associated pathology.
Submitted on September 13, 1994
This article has been cited by other articles:
![]() |
S. Vrielynck, T. Mamou-Mani, S. Emond, P. Scheinmann, F. Brunelle, and J. de Blic Diagnostic Value of High-Resolution CT in the Evaluation of Chronic Infiltrative Lung Disease in Children Am. J. Roentgenol., September 1, 2008; 191(3): 914 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Latzin, M Tredano, Y Wust, J de Blic, T Nicolai, B Bewig, F Stanzel, D Kohler, M Bahuau, and M Griese Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis Thorax, January 1, 2005; 60(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Seymour and J. J. Presneill Pulmonary Alveolar Proteinosis: Progress in the First 44 Years Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 215 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L Shah, D. Hansell, P. R Lawson, K. B M Reid, and C. Morgan Rare diseases bullet 6: Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis Thorax, January 1, 2000; 55(1): 67 - 77. [Full Text] |
||||
![]() |
J. A. Boyce and E. J. Mark Case 40-1999- A Four-Month-Old Girl with Chronic Cyanosis and Diffuse Pulmonary Infiltrates N. Engl. J. Med., December 30, 1999; 341(27): 2075 - 2083. [Full Text] [PDF] |
||||
![]() |
E. Sivitanidis, R. Tosson, A. Wiebalck, and A. Laczkovics Combination of extracorporeal membrane oxygenation (ECMO) and pulmonary lavage in a patient with pulmonary alveolar proteinosis Eur. J. Cardiothorac. Surg., March 1, 1999; 15(3): 370 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spock Pulmonary Alveolar Proteinosis Pediatrics, May 1, 1997; 99(5): 756 - 756. [Full Text] [PDF] |
||||